FdaApplication
NDA 009218
Identifiers
- fda_app_no: NDA009218
Properties
| Property | Value |
|---|---|
| applicant_name | BRISTOL MYERS SQUIBB PHARMA CO |
| application_type | NDA |
| approval_date | 1990-03-01 |
Products (12)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| COUMADIN | WARFARIN SODIUM | 7.5MG | TABLET;ORAL |
| COUMADIN | WARFARIN SODIUM | 2.5MG | TABLET;ORAL |
| COUMADIN | WARFARIN SODIUM | 4MG | TABLET;ORAL |
| COUMADIN | WARFARIN SODIUM | 6MG | TABLET;ORAL |
| COUMADIN | WARFARIN SODIUM | 10MG | TABLET;ORAL |
| COUMADIN | WARFARIN SODIUM | 5MG/VIAL | INJECTABLE;INJECTION |
| COUMADIN | WARFARIN SODIUM | 75MG/VIAL | INJECTABLE;INJECTION |
| COUMADIN | WARFARIN SODIUM | 5MG | TABLET;ORAL |
| COUMADIN | WARFARIN SODIUM | 3MG | TABLET;ORAL |
| COUMADIN | WARFARIN SODIUM | 2MG | TABLET;ORAL |
| COUMADIN | WARFARIN SODIUM | 50MG/VIAL | INJECTABLE;INJECTION |
| COUMADIN | WARFARIN SODIUM | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
12 products